Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Harmonization Task Force To Disband As Focus Shifts To Implementation

This article was originally published in The Gray Sheet

Executive Summary

The Global Harmonization Task Force as currently formed will disband and be replaced with a new, regulators-only forum focused on implementing harmonized policies across the globe, participants say.

You may also be interested in...



As GHTF Ends, Industry Cautiously Optimistic On Future Harmonization Progress Under IMDRF

As the Global Harmonization Task Force held its final meeting last week in Tokyo, members of industry met separately to discuss how GHTF’s work will be carried on by the International Medical Device Regulators Forum.

International News In Brief

GHTF Issues Final Guidance Documents On UDI And Device Labeling

The Global Harmonization Task Force has released two final guidance documents – on unique device identification systems and device instructions for use – plus four proposed guidelines in recent weeks.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel